Skip to Main Content

Author Details

Christopher D Gocke
Johns Hopkins University School of Medicine
1992
188
40
PMIDPaper TitleJournal TitlePublished Year
37236162Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report.Blood Adv2023
37841697Plexiform neurofibroma of the liver, with malignant transformation to MPNST, in a pediatric patient without neurofibromatosis type 1.Neurooncol Adv2023
37926709Donor cell-derived genetic abnormalities after sex mismatched allogeneic cell transplantation: a unique challenge of donor cell leukemia.Blood Cancer J2023
37583476The Genomics Organization for Academic Laboratories (GOAL): A vision for a genomics future for academic pathology.Acad Pathol2023
38001699Ring Chromosomes in Hematological Malignancies Are Associated with <i>TP53</i> Gene Mutations and Characteristic Copy Number Variants.Cancers (Basel)2023
37806433Recommendations for Cell-Free DNA Assay Validations: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.J Mol Diagn2023
37090662The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts.Res Sq2023
37276081Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes.Blood Adv2023
37140166Familial Clonal Hematopoiesis in a Long Telomere Syndrome.N Engl J Med2023
37440250Novel PAX3::INO80D Fusion in Biphenotypic Sinonasal Sarcoma in an Adult.JAMA Otolaryngol Head Neck Surg2023
37372318Complex/cryptic <i>EWSR1::FLI1/ERG</i> Gene Fusions and 1q Jumping Translocation in Pediatric Ewing Sarcomas.Genes (Basel)2023
37236162Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report.Blood Adv2023
37354804Co-occurring mutations in ASXL1, SRSF2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia.Leuk Res2023
37350948Colorectal cancer in patients of advanced age is associated with increased incidence of <i>BRAF</i> p.V600E mutation and mismatch repair deficiency.Front Oncol2023
37806433Recommendations for Cell-Free DNA Assay Validations: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.J Mol Diagn2023
38001699Ring Chromosomes in Hematological Malignancies Are Associated with <i>TP53</i> Gene Mutations and Characteristic Copy Number Variants.Cancers (Basel)2023
37583476The Genomics Organization for Academic Laboratories (GOAL): A vision for a genomics future for academic pathology.Acad Pathol2023
37841697Plexiform neurofibroma of the liver, with malignant transformation to MPNST, in a pediatric patient without neurofibromatosis type 1.Neurooncol Adv2023
37926709Donor cell-derived genetic abnormalities after sex mismatched allogeneic cell transplantation: a unique challenge of donor cell leukemia.Blood Cancer J2023
37354804Co-occurring mutations in ASXL1, SRSF2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia.Leuk Res2023
37090662The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts.Res Sq2023
37350948Colorectal cancer in patients of advanced age is associated with increased incidence of <i>BRAF</i> p.V600E mutation and mismatch repair deficiency.Front Oncol2023
37440250Novel PAX3::INO80D Fusion in Biphenotypic Sinonasal Sarcoma in an Adult.JAMA Otolaryngol Head Neck Surg2023
37372318Complex/cryptic <i>EWSR1::FLI1/ERG</i> Gene Fusions and 1q Jumping Translocation in Pediatric Ewing Sarcomas.Genes (Basel)2023
37276081Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes.Blood Adv2023
37140166Familial Clonal Hematopoiesis in a Long Telomere Syndrome.N Engl J Med2023
34107771Short Communication: Persistence of HIV After Allogeneic Bone Marrow Transplant in a Dually Infected Individual.AIDS Res Hum Retroviruses2022
35561840Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens.Hum Pathol2022
35730391Clonal hematopoiesis in men living with HIV and association with subclinical atherosclerosis.AIDS2022
34107771Short Communication: Persistence of HIV After Allogeneic Bone Marrow Transplant in a Dually Infected Individual.AIDS Res Hum Retroviruses2022
34519764Double PIK3CA Alterations and Parallel Evolution in Colorectal Cancers.Am J Clin Pathol2022
35312750Artificial Intelligence-Assisted Serial Analysis of Clinical Cancer Genomics Data Identifies Changing Treatment Recommendations and Therapeutic Targets.Clin Cancer Res2022
34793200Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.J Clin Oncol2022
35149321Lynch syndrome caused by a novel deletion of the promoter and exons 1-13 of MLH1 gene.Cancer Genet2022
34753870Brief Report: Rebound HIV Viremia With Meningoencephalitis After Antiretroviral Therapy Interruption After Allogeneic Bone Marrow Transplant.J Acquir Immune Defic Syndr2022
35730391Clonal hematopoiesis in men living with HIV and association with subclinical atherosclerosis.AIDS2022
35561840Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens.Hum Pathol2022
35312750Artificial Intelligence-Assisted Serial Analysis of Clinical Cancer Genomics Data Identifies Changing Treatment Recommendations and Therapeutic Targets.Clin Cancer Res2022
35149321Lynch syndrome caused by a novel deletion of the promoter and exons 1-13 of MLH1 gene.Cancer Genet2022
34793200Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.J Clin Oncol2022
34519764Double PIK3CA Alterations and Parallel Evolution in Colorectal Cancers.Am J Clin Pathol2022
34753870Brief Report: Rebound HIV Viremia With Meningoencephalitis After Antiretroviral Therapy Interruption After Allogeneic Bone Marrow Transplant.J Acquir Immune Defic Syndr2022
34233240Concomitance of a novel RMDN2-ALK fusion and an EML4-ALK fusion in a lung adenocarcinoma.Cancer Genet2021
33909482Feasibility of Cell-Free DNA Collection and Clonal Immunoglobulin Sequencing in South African Patients With HIV-Associated Lymphoma.JCO Glob Oncol2021
34233240Concomitance of a novel RMDN2-ALK fusion and an EML4-ALK fusion in a lung adenocarcinoma.Cancer Genet2021
33577993Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies.J Mol Diagn2021
34209587Germline <i>ERBB2</i>/<i>HER2</i> Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms.Cancers (Basel)2021
33929516IDH1 and IDH2 Mutations in Colorectal Cancers.Am J Clin Pathol2021
34358677Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens.J Mol Diagn2021
34491318CloneRetriever: An Automated Algorithm to Identify Clonal B and T Cell Gene Rearrangements by Next-Generation Sequencing for the Diagnosis of Lymphoid Malignancies.Clin Chem2021
  • 1 - 50 of 376

Recommended Authors

Markus Ball
Institute of Pathology, Heidelberg University Hospital
Career Start Year 2010
Number of shared co-authors 0
David Wu
University of Washington
Career Start Year 2010
Number of shared co-authors 4
Jennifer Dunlap
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 2
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 4
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 5
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 4
Catrina Fronick
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 4
Peter J Campbell
Wellcome Sanger Institute
Career Start Year 2003
Number of shared co-authors 2
Fei Yang
Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 0
Guang Fan
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 2
Marilyn M Li
Children's Hospital of Philadelphia
Career Start Year 2000
Number of shared co-authors 2
Lawrence J Jennings
Northwestern University Feinberg School of Medicine
Career Start Year 1998
Number of shared co-authors 1
Jason D Merker
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 1998
Number of shared co-authors 1
Shashikant Kulkarni
Centene Center for Health Transformation, Centene Corporation
Career Start Year 1998
Number of shared co-authors 4
David M Weinstock
Merck & Co.
Career Start Year 1998
Number of shared co-authors 3
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 6
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 1
Francisco Vega
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 4
Lucy A Godley
The University of Chicago
Career Start Year 1994
Number of shared co-authors 6
Jean Soulier
University of Paris
Career Start Year 1993
Number of shared co-authors 1
Seishi Ogawa
Kyoto University
Career Start Year 1993
Number of shared co-authors 3
Mark J Routbort
University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 3
Richard D Press
Oregon Health and Science University
Career Start Year 1988
Number of shared co-authors 2
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 2
Cindy L Vnencak-Jones
Vanderbilt University Medical Center
Career Start Year 1987
Number of shared co-authors 3
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Career Start Year 1984
Number of shared co-authors 11
David M Dorfman
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1982
Number of shared co-authors 1
Elias Campo
Institute for Biomedical Research August Pi I Sunyer
Career Start Year 1981
Number of shared co-authors 5
Mark Raffeld
Center for Cancer Research, National Cancer Institute
Career Start Year 1981
Number of shared co-authors 10

Collaborators

Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers 23
Mark J Levis
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 14
Aparna Pallavajjala
Johns Hopkins University School of Medicine
Co-authored papers 11
William Matsui
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Co-authored papers 8
Robert A Brodsky
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers 5
Ben Ho Park
Vanderbilt University Medical Center
Co-authored papers 4
Christine A Pratilas
Johns Hopkins University School of Medicine
Co-authored papers 4
Sarah J Wheelan
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 4
Fausto J Rodriguez
University of California Los Angeles
Co-authored papers 4
Emmanuel S Antonarakis
The Sidney Kimmel Cancer Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 2
Peter C Burger
Co-authored papers 2
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Co-authored papers 2
Hua Ling
Chongqing Center for Disease Control and Prevention.
Co-authored papers 2
Peter K Rogan
CytoGnomix Inc.
Co-authored papers 2
Donald Small
Johns Hopkins University School of Medicine
Co-authored papers 2
Nara Sobreira
Johns Hopkins University
Co-authored papers 2
Vered Stearns
Co-authored papers 2
Donna M Williams
Johns Hopkins University School of Medicine
Co-authored papers 2
Christian F Meyer
Johns Hopkins University School of Medicine
Co-authored papers 2
Elaine S Jaffe
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Alison R Moliterno
Johns Hopkins Hospital
Co-authored papers 2
Antonio C Wolff
Co-authored papers 2
Victor E Velculescu
Co-authored papers 2
Richard Hildreth
George Washington University
Co-authored papers 1
Joel E Gallant
Co-authored papers 1
Alan S Wayne
Cancer and Blood Disease Institute, Children's Hospital Los Angeles
Co-authored papers 1
Bret Helton
University of Washington
Co-authored papers 1
Patrick Brown
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Linzhao Cheng
Johns Hopkins University School of Medicine
Co-authored papers 1
Release 1.2